Early in the coronavirus disease 2019 (COVID-19) pandemic, global governing bodies
prioritized transmissibility-based precautions and hospital capacity as the foundation for …

The coronavirus disease 2019 (COVID-19), a deadly pandemic that has affected millions of
people worldwide, is associated with cardiovascular complications, including venous and …

Coronavirus disease 2019 (COVID-19) increases the risk of thromboembolic events,
especially in patients with severe infections requiring intensive care and cardiorespiratory …

SARS-CoV-2, a novel coronavirus found in Wuhan (China) at the end of 2019, is the
etiological agent of the current pandemic that is a heterogeneous disease, named …

Background The clinical spectrum of acute SARS-CoV-2 infection ranges from an
asymptomatic to life-threatening disease. Considering the broad spectrum of severity …

Background The current COVID-19 pandemic from the human pathogenic virus SARS-CoV-
2 has resulted in a major health hazard globally. The morbidity and transmission modality of …

Summary Background The SARS-CoV-2 pandemic is a worldwide challenge. The CRIT-
CoV-U pilot study generated a urinary proteomic biomarker consisting of 50 peptides …

On 11 March 2020, the WHO declared the coronavirus disease 2019 (COVID-19) outbreak a
pandemic and COVID-19 emerged as one of the biggest challenges in public health and …

Abstract Coronavirus disease (COVID-19) has caused extensive mortality globally;
therefore, biomarkers predicting the severity and prognosis of COVID-19 are essential. This …

This study aimed to characterize the changes in serum inflammatory mediators in
hospitalized patients with COVID-19 correlating with death. The study includes 58 …